Sen. John Hoeven bought The Procter & Gamble Company (PG)

Sen. John Hoeven (R-ND) · $100K–$250K · traded Jan 20, 2017

Transaction: Bought
Amount: $100K–$250K
Owner: The member
Traded: Jan 20, 2017
Disclosed: Jan 25, 2017
Days to disclose: 5
Asset type: Stock
As filed: The Procter & Gamble Company
Industry: Household & Personal Products · Consumer Defensive

Official filing ↗All of Hoeven's trades All Congress trades in PG

Other trades in this filing

DisclosedTradeAmount

Jan 25, 2017
Sold (full) Merck & Co. MRK
$50K–$100K · Traded Jan 25, 2017 · disclosed Jan 25, 2017
$50K–$100K
Jan 25, 2017
Bought Willis Towers Watson Public Limited Company WTW
$50K–$100K · Traded Jan 24, 2017 · disclosed Jan 25, 2017
$50K–$100K
Jan 25, 2017
Bought V.F. VFC
$50K–$100K · Traded Jan 23, 2017 · disclosed Jan 25, 2017
$50K–$100K
Jan 25, 2017
Bought Cisco Systems CSCO
$100K–$250K · Traded Jan 20, 2017 · disclosed Jan 25, 2017
$100K–$250K
Jan 25, 2017
Bought Verizon Communications VZ
$50K–$100K · Traded Jan 20, 2017 · disclosed Jan 25, 2017
$50K–$100K
Jan 25, 2017
Sold (full) Johnson & Johnson JNJ
$100K–$250K · Traded Jan 20, 2017 · disclosed Jan 25, 2017
$100K–$250K
Jan 25, 2017
Sold (full) Pfizer PFE
$50K–$100K · Traded Jan 20, 2017 · disclosed Jan 25, 2017
$50K–$100K
Jan 25, 2017
Bought Intel INTC
$50K–$100K · Traded Jan 20, 2017 · disclosed Jan 25, 2017
$50K–$100K
Jan 25, 2017
Bought The Coca-Cola Company KO
$100K–$250K · Traded Jan 20, 2017 · disclosed Jan 25, 2017
$100K–$250K
Jan 25, 2017
Sold (full) Bristol-Myers Squibb Company BMY
$50K–$100K · Traded Jan 20, 2017 · disclosed Jan 25, 2017
$50K–$100K
Jan 25, 2017
Bought PepsiCo PEP
$100K–$250K · Traded Jan 20, 2017 · disclosed Jan 25, 2017
$100K–$250K
Jan 25, 2017
Sold (full) Amgen AMGN
$50K–$100K · Traded Jan 20, 2017 · disclosed Jan 25, 2017
$50K–$100K
Jan 25, 2017
Sold (full) AbbVie ABBV
$100K–$250K · Traded Jan 20, 2017 · disclosed Jan 25, 2017
$100K–$250K
Jan 25, 2017
Bought AT&T T
$50K–$100K · Traded Jan 20, 2017 · disclosed Jan 25, 2017
$50K–$100K
Jan 25, 2017
Sold (full) THE CAMPBELL FUND TRUST - SERIES A Company: THE CAMPBELL FUND TRUST - SERIES A (BALTIMORE, MARYLAND) Description: INVETMENT MANAGEMENT IN FUTURES AND CASH EQUITY STRATEGIES
$50K–$100K · Traded Jan 12, 2017 · disclosed Jan 25, 2017
$50K–$100K

Recent Congress trades in PG

DisclosedTradeAmount

Oct 28, 2026
Rep. Pete Sessions (R-TX-17)
Sold The Procter & Gamble Company PG
$1K–$15K · Traded Oct 8, 2026 · disclosed Oct 28, 2026
$1K–$15K
Oct 16, 2026
Rep. David J. Taylor (R-OH-2)
Sold The Procter & Gamble Company PG
$1K–$15K · Traded Oct 12, 2026 · disclosed Oct 16, 2026
$1K–$15K
Oct 9, 2026
Rep. Ro Khanna (D-CA-17)
Bought The Procter & Gamble Company PG
$1K–$15K · Traded Sep 25, 2026 · disclosed Oct 9, 2026 · Spouse
$1K–$15K
Oct 9, 2026
Rep. Ro Khanna (D-CA-17)
Bought The Procter & Gamble Company PG
$1K–$15K · Traded Sep 11, 2026 · disclosed Oct 9, 2026 · Dependent
$1K–$15K
Oct 9, 2026
Rep. Ro Khanna (D-CA-17)
Sold The Procter & Gamble Company PG
$1K–$15K · Traded Sep 2, 2026 · disclosed Oct 9, 2026 · Dependent
$1K–$15K
Oct 9, 2026
Rep. Ro Khanna (D-CA-17)
Sold The Procter & Gamble Company PG
$1K–$15K · Traded Sep 2, 2026 · disclosed Oct 9, 2026 · Spouse
$1K–$15K
Sep 18, 2026
Rep. David J. Taylor (R-OH-2)
Bought The Procter & Gamble Company PG
$1K–$15K · Traded Sep 8, 2026 · disclosed Sep 18, 2026
$1K–$15K
Sep 9, 2026
Rep. Lloyd Doggett (D-TX-37)
Bought The Procter & Gamble Company PG
$1K–$15K · Traded Aug 17, 2026 · disclosed Sep 9, 2026
$1K–$15K

From a periodic transaction report filed under the STOCK Act. Amounts are the ranges members report. Nothing here is investment advice.